↓ Skip to main content

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Overview of attention for article published in The Lancet, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 39,475)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
968 Dimensions

Readers on

mendeley
1825 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Published in
The Lancet, February 2021
DOI 10.1016/s0140-6736(21)00234-8
Pubmed ID
Authors

Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, Anna V Kovyrshina, Nadezhda L Lubenets, Daria M Grousova, Alina S Erokhova, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Vladimir A Gushchin, Elena A Smolyarchuk, Sergey K Zyryanov, Sergei V Borisevich, Boris S Naroditsky, Alexander L Gintsburg

Twitter Demographics

The data shown below were collected from the profiles of 43,344 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1,825 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1825 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 310 17%
Researcher 228 12%
Student > Master 151 8%
Student > Ph. D. Student 145 8%
Other 114 6%
Other 350 19%
Unknown 527 29%
Readers by discipline Count As %
Medicine and Dentistry 476 26%
Biochemistry, Genetics and Molecular Biology 184 10%
Agricultural and Biological Sciences 95 5%
Immunology and Microbiology 80 4%
Pharmacology, Toxicology and Pharmaceutical Science 76 4%
Other 307 17%
Unknown 607 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 27618. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2022.
All research outputs
#11
of 21,799,263 outputs
Outputs from The Lancet
#1
of 39,475 outputs
Outputs of similar age
#3
of 418,640 outputs
Outputs of similar age from The Lancet
#1
of 390 outputs
Altmetric has tracked 21,799,263 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 39,475 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 65.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,640 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 390 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.